[1] Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: A summary[J]. Acta Neuropathol, 2016, 131(6): 803-820. [2] Pedersen PH, Rucklidge GJ, Mørk SJ, et al. Leptomeningeal tissue: a barrier against brain tumor cell invasion[J]. J Natl Cancer Inst, 1994, 86(21): 1593-1599. [3] Rios Garcia M, Steinber B, Srivastava K, et al. Acetyl-CoA carboxylase 1-dependent protein acetylation controls breast cancer metastasis and recurrence[J]. Cell Metab, 2017, 26(6): 842-855. [4] Ye B, Yin L, Wang Q, et al. ACC1 is overexpressed in liver cancers and contributes to the proliferation of human hepatoma HepG2 cells and the rat liver cell line BRL 3A[J]. Mol Med Rep, 2019, 19(5): 3431-3440. [5] 孔晓霞, 张宏宇, 陈 然, 等. 神经胶质瘤U251细胞氧化损伤中自噬和凋亡过程中的时间顺序[J]. 中国应用生理学杂志, 2011, 27(4): 471-474. [6] Berod L, Friedrich C, Nandan A, et al. De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells[J]. Nat Med, 2014, 20(11): 1327-1333. [7] Sivanand S, Viney I, Wellen KE. Spatiotemporal control of acetyl-CoA metabolism in chromatin regulation[J]. Trends Biochem Sci, 2018, 43(1): 61-74. [8] Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses[J]. Neoplasia, 2017, 19(8): 649-658. [9] Jones JE, Esler WP, Patel R, et al. Inhibition of Acetyl-CoA Carboxylase 1 (ACC1) and 2 (ACC2) reduces proliferation and de novo lipogenesis of EGFRvIII human glioblastoma cells[J]. PLoS One, 2017, 12(1): e0169566. [10] 王 阳, 赵宝生, 李超红, 等.乙酰辅酶A羧化酶1对胶质瘤细胞系U87细胞增殖、迁移和侵袭的影响[J]. 解剖学报, 2022, 53(3): 317-322. [11] Nan Y, Guo L, Lu Y, et al. miR-451 suppresses EMT and metastasis in glioma cells[J]. Cell Cycle, 2021, 20(13): 1270-1278. [12] Oh SJ, Ahn EJ, Kim O, et al. The role played by SLUG, an epithelial-mesenchymal transition factor, in invasion and therapeutic resistance of malignant glioma[J]. Cell Mol Neurobiol, 2019, 39(6): 769-782. [13] 周立君, 梅轶芳, 王岚峰, 等. 同型半胱氨酸对人脐静脉血管内皮细胞tPA及PAI-1基因表达的影响[J].中国应用生理学杂志, 2004, 20(4): 363-366. [14] Wu DM, Wang S, Wen X,et al. MircoRNA-1275 promotes proliferation, invasion and migration of glioma cells via SERPINE1[J]. J Cell Mol Med, 2018, 22(10): 4963-4974. [15] Xi X, Liu N, Wang Q, et al. ACT001, a novel PAI-1 inhibitor, exerts synergistic effects in combination withcisplatin by inhibiting PI3K/AKT pathway in glioma[J]. Cell Death Dis, 2019, 10(10): 757-764. [16] 许 晶. 上皮间充质转化诱导的PAI-1促进三阴性乳腺癌细胞侵袭和转移的机制研究[D]. 南京医科大学, 2019. [17] Wang D, Yang LY, Liu Z, et al. PAI-1 overexpression promotes invasion and migration of esophageal squamous carcinoma cells[J]. Yi Chuan, 2020, 42(3): 287-295. [18] Sun L, Zhang H, Gao P. Metabolic reprogramming and epigenetic modifications on the path to cancer[J]. Protein Cell, 2022, 13(12): 877-919. [19] Tong Q, Weaver MR, Kosmacek EA, et al. MnTE-2-PyP reduces prostate cancergrowth and metastasis by suppressing p300 activity and p300/HIF-1/CREB binding to the promoter region of the PAI-1 gene[J]. Free Radic Biol Med, 2016, 94: 185-194. [20] Liu D, Liu Y, Qi B, et al. Trichostatin A promotes esophageal squamous cell carcinoma cell migration and EMT through BRD4/ERK1/2-dependent pathway[J]. Cancer Med, 2021, 10(15): 5235-5245. |